Trial Profile
To compare the efficacy of first line Bevacizumab plus chemotherapy with chemotherapy alone in patients with metastatic colorectal cancer: an observational, cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jun 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Fluorouracil; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms GRETA
- 16 Oct 2017 New trial record
- 12 Oct 2017 Results presented at the 20th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research